News

ESMT Press | The German Spin-off Framework is a voluntary commitment by research institutions, technology transfer offices, and investors to common standards and best practices for research-based spin-offs. The framework aims to reduce friction, increase transparency, and help founders, investors, and research organizations focus on building globally competitive deep tech companies.

State Capital Potsdam | The State Capital Potsdam has received important feedback from the Ministry of Agriculture, Environment, Consumer Protection and Climate Action regarding the planned development of Golm Nord. In a letter, the Ministry confirms that approval of the proposed building areas as part of the “Golm Nord” land-use plan amendment is not obviously…

On 24 September 2026, the Fraunhofer Conference Center at Potsdam Science Park will become the meeting place for DeepTech startups, researchers, venture capital investors, companies, and innovation leaders. Under the title “PSP Conference 2026 – RESTART”, the conference invites participants to explore the future of DeepTech innovation and Germany’s startup ecosystem, forge new partnerships, and…

We are committed! From June 2 to 22, 2026, we are turning our everyday journeys into a contribution towards a better world. The Potsdam Science Park is calling on all employees, students, residents, and partners: get on your bike and join us as part of the “Potsdam Science Park” team in the CITY CYCLING campaign!

On 9 May 2026, the 13th Potsdam Day of Science will take place – on the Golm Campus of the University of Potsdam! More than 40 universities, schools and research institutions in Brandenburg will present their everyday working life. We will be there with the Potsdam Science Park in the Research Camp at Stand 2…

Raamsdonksveer, Netherlands / Potsdam, Germany, April 1, 2026 – In the presence of the Mayor of the City of Potsdam, Ms. Noosha Aubel, the Dopharma Group and its wholly owned subsidiary Ripac-Labor GmbH celebrated the topping-out ceremony for their new, state-of-the-art production facility for autogenous vaccines.